Provided by Tiger Trade Technology Pte. Ltd.

ZYMEWORKS INC (US)

28.67
+2.107.90%
Post-market: 28.940.2700+0.94%19:40 EDT
Volume:836.38K
Turnover:23.54M
Market Cap:2.03B
PE:-14.19
High:28.74
Open:26.97
Low:26.77
Close:26.57
52wk High:29.75
52wk Low:13.60
Shares:70.96M
Float Shares:66.05M
Volume Ratio:1.51
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0200
EPS(LYR):-1.0800
ROE:-72.31%
ROA:-24.14%
PB:25.31
PE(LYR):-26.55

Loading ...

Zymeworks - Deal Expected to be Accretive to Earnings and Cash Flow

THOMSON REUTERS
·
Jun 29

Zymeworks - to Retain $2.5 Bln Irish Tax Attributes from Theravance Biopharma

THOMSON REUTERS
·
Jun 29

Zymeworks - Theravance Biopharma Expected to Receive $100 Mln Trelegy Ellipta Milestone in Q1 2027

THOMSON REUTERS
·
Jun 29

Zymeworks to Acquire Theravance Biopharma, Inc.

THOMSON REUTERS
·
Jun 29

Zymeworks Said to Near $929 Million Deal for Theravance - Bloomberg News

Reuters
·
Jun 29

Zymeworks is Discussing Paying $17 Per Share for Theravance- Bloomberg News

THOMSON REUTERS
·
Jun 29

ZW191’s Broad Phase 1 Activity in Ovarian Cancer Could Be A Game Changer For Zymeworks (ZYME)

Simply Wall St.
·
Jun 23

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Maze Therapeutics, Inc. (MAZE) and Universal Health (UHS)

TIPRANKS
·
Jun 22

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Amylyx Pharmaceuticals Inc (AMLX) and AbCellera Biologics (ABCL)

TIPRANKS
·
Jun 18

Zymeworks partners with Gandeeva to generate cryo-EM structural data for antibody discovery

Reuters
·
Jun 18

Zymeworks Reports Promise With Anti-Cancer Drug

MT Newswires Live
·
Jun 15

Zymeworks presents new clinical data on Phase 1 study of ZW191

TIPRANKS
·
Jun 15

Zymeworks says Phase 1 data show ZW191 ADC posts 78.6% response rate in FRα-positive platinum-resistant ovarian cancer patients

Reuters
·
Jun 15

Analysts Offer Insights on Healthcare Companies: Perrigo Company (PRGO) and Zymeworks (ZYME)

TIPRANKS
·
Jun 09

Zymeworks Price Target Maintained With a $46.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 03

Zymeworks files Form 3 for EVP, General Counsel Paul R. Schneider

Reuters
·
May 16

Zymeworks authorizes share repurchase program of up to $125M

TIPRANKS
·
May 15

Zymeworks Announces Share Repurchase Program of up to $125 Million of Its Common Stock

THOMSON REUTERS
·
May 15

Zymeworks management to join Stifel Virtual Targeted Oncology Forum fireside chat

Reuters
·
May 13

Citi Reaffirms Their Buy Rating on Zymeworks (ZYME)

TIPRANKS
·
May 10